Drug Evaluation Committee Information about the "Workshop for Promoting QMS Implementation - Experiencing Approaches to Organizational Issues" event for pharmaceutical companies/CROs (face-to-face: 2025/3/4)

Jan 22, 2025

The Clinical Evaluation Subcommittee of the Committee on Drug Evaluation of the Japan Pharmaceutical Manufacturers Association (JPMA) is pleased to announce a workshop aimed at promoting QMS implementation in sponsors and CROs. This workshop will be held to promote QMS implementation by sponsors and CROs, which will be released in September 2024. Approaches to QMS Implementation by Clinical Research Sponsors - Fostering a Culture of Quality and Demonstrating Leadership and is planned as a forum for dialogue on solutions to QMS implementation issues.

Through this workshop, we aim for participants to take away tips for QMS implementation and promotion through dialogue incorporating the perspective of "Fostering a Culture of Quality and Demonstrating Leadership".

For more information on how to register and details of the workshop, QMS Implementation Promotion Workshop: Experiencing Approaches to Organizational Issues We look forward to the participation of not only QMS professionals, but also monitors, study planners, and many others.

The series of activities by the Clinical Evaluation Task Force related to quality management that have been conducted for the past several years, including this workshop, will be completed this year. We welcome those who have already participated in other projects, so please take advantage of this opportunity.

Registration deadline: Friday, February 21, 2025
How to register: Please register via the following URL or QR code.
URL: https://form.qooker.jp/Q/auto/ja/25TF2QMSwspre/QMSWSpre/

Return to Drug Evaluation Committee Symposium Top

TOP